Introduction {#sec1}
============

The skin is a highly regenerative organ containing distinct populations of adult precursors that serve to maintain this regenerative capacity. One of these is a SOX2-positive dermal precursor that resides in hair follicles and that can regenerate the dermis and induce hair follicle morphogenesis ([@bib4; @bib9]). When these cells (termed skin-derived precursors, or SKPs) are expanded in culture, they differentiate into mesenchymal cell types like smooth muscle cells, adipocytes, and dermal fibroblasts ([@bib4; @bib15; @bib26; @bib27; @bib28]) and peripheral neural cells such as Schwann cells ([@bib3; @bib11; @bib21]). This differentiation repertoire is reminiscent of embryonic neural crest precursors and, consistent with this, SKPs exhibit many neural crest precursor-like properties ([@bib9]). However, lineage tracing recently showed that SKPs isolated from facial skin come from the neural crest, while SKPs from dorsal skin derive instead from a somite origin ([@bib13]), as does the rest of the dorsal dermis ([@bib19]). In spite of these different origins, dorsal and facial SKPs are very similar at the transcriptome level ([@bib13]).

These findings indicate that cells of different developmental origins can converge to generate somatic tissue precursor cells with highly similar phenotypes. However, they also raise a number of important questions. In particular, while it is generally thought that only the neural crest generates peripheral neural cells like Schwann cells, these findings suggest that mesenchymal precursors of nonneural crest origin might have the same capacity. Support for this idea comes from studies showing that functional Schwann cells can be generated from mesenchymal precursors (for example, see [@bib21; @bib5]) and that genetic manipulation can reprogram dermal cells directly into functional neural progeny (reviewed in [@bib1]). However, these findings are complicated by the fact that neural crest precursors are present in peripheral nerves and thus potentially in mesenchymal cell preparations from skin or other innervated tissues. For example, we showed that SKPs from dorsal dermis generated Schwann cells ([@bib21; @bib3]), but others suggested these were of neural crest origin ([@bib30]). Thus, a key question is whether these neural progeny derive from mesenchymal precursors or from widespread neural crest precursors.

Here, we have used lineage tracing to address this issue and show that nonneural crest dermal mesenchymal cells can generate myelinating Schwann cells that are highly similar to nerve-derived Schwann cells. This is not a mouse-specific phenomenon, since highly similar SKPs can be made from neonatal human foreskin and facial dermis, tissues thought to be mesodermally versus neural crest derived, respectively. In addition, the human foreskin SKPs make myelinating Schwann cells. Thus, nonneural crest-derived mesenchymal precursors can differentiate into bona fide peripheral glia in the absence of genetic manipulation, indicating that developmentally defined lineage boundaries are more flexible than widely thought.

Results {#sec2}
=======

Dorsal Rodent SKPs Derive from Dermal Mesenchymal Cells {#sec2.1}
-------------------------------------------------------

We previously showed that rodent facial SKPs come from the neural crest, whereas SKPs from the dorsal dermis derive from *Myf5-Cre-*positive cells, a marker for a somite origin ([@bib13]). To definitively ask whether dorsal SKPs come from dermal mesenchymal cells, we used mice with Cre recombinase knocked in to the *Dermo1* locus (*Dermo1*^*Cre/+*^ mice; [@bib31]). Dermo1 is a basic helix-loop-helix that is expressed in embryonic dermal cells and some other mesenchymal cell types ([@bib17]). We crossed the *Dermo1*^*Cre/+*^ mice to mice with a floxed YFP gene in the *Rosa26* locus to cause Cre-dependent expression of YFP in dermal mesenchymal precursors and their progeny. Immunostaining of dorsal skin from *Dermo1*^*Cre/+*^*;R26YFP*^*fl/+*^ mice showed that virtually all dermal cells were YFP positive, including those thought to give rise to SKPs, the neural cell adhesion molecule (NCAM)-positive cells in the hair follicle dermal papilla and smooth muscle actin (SMA)-positive cells in the dermal sheath ([Figures 1](#fig1){ref-type="fig"}A--1C). In contrast, neural crest-derived cells, including tyrosinase-positive melanocytes and S100β-positive Schwann cells in skin nerves, were YFP negative ([Figures 1](#fig1){ref-type="fig"}D and 1E).

To confirm that Schwann cells were negative for the reporter, we examined the sciatic nerve of *Dermo1*^*Cre/+*^*;R26TdTomato*^*fl/+*^ mice. TdTomato-positive cells were present in the nerve epineurium and perineurium, with the occasional positive cell in nerve fascicles, likely endoneurial fibroblasts. None of these cells colocalized with the Schwann cell marker S100β ([Figures 1](#fig1){ref-type="fig"}F and 1G), although they were positive for fibronectin and CD34 ([Figures 1](#fig1){ref-type="fig"}H and 1I). Thus, dorsal mesenchymal and not neural crest cells are labeled in these mice.

We therefore cultured SKPs from neonatal dorsal dermis of *Dermo1*^*Cre/+*^*;R26YFP*^*fl/+*^ mice to ask whether they came from mesenchymal cells. Almost all spheres were positive for YFP ([Figure 2](#fig2){ref-type="fig"}A) as well as SOX2 ([Figure 2](#fig2){ref-type="fig"}B), nestin, and fibronectin ([Figure 2](#fig2){ref-type="fig"}C), well-characterized SKP markers. Similar results were obtained following passaging ([Figures 2](#fig2){ref-type="fig"}E--2H). Sectioning of spheres from *Dermo1*^*Cre/+*^*;R26TdTomato*^*fl/+*^ mice ([Figure 2](#fig2){ref-type="fig"}D) showed that virtually all cells were positive for the TdTomato reporter. To address the possibility that *Dermo1-cre* might be turned on by the culture conditions, we sorted YFP-positive and negative cells from *Dermo1*^*Cre/+*^*;R26YFP*^*fl/+*^ dorsal skin ([Figure 2](#fig2){ref-type="fig"}I) and cultured them under SKP conditions. Only YFP-positive cells made spheres ([Figure 2](#fig2){ref-type="fig"}J), as we previously observed with *Myf5-cre-*positive dorsal dermal cells ([@bib13]). Thus, dorsal SKPs originate from dermal mesenchymal cells that are somite, and not neural crest, derived.

SKPs Generated from Dermal Mesenchymal Cells Differentiate into Functional Schwann Cells {#sec2.2}
----------------------------------------------------------------------------------------

We next asked whether mesenchymally derived SKPs could differentiate into Schwann cells. To obtain pure populations of reporter gene-positive SKPs, we made spheres from dorsal skin of neonatal *Dermo1*^*Cre/+*^*;R26YFP*^*fl/+*^ or *Dermo1*^*Cre/+;*^*R26TdTomato*^*fl/+*^ mice (as shown in [Figures 2](#fig2){ref-type="fig"}A--2H), dissociated the spheres, and sorted cells for YFP or TdTomato ([Figure 2](#fig2){ref-type="fig"}K). Consistent with the sectioning data ([Figure 2](#fig2){ref-type="fig"}D), almost all sphere cells were reporter gene positive ([Figure 2](#fig2){ref-type="fig"}K). We then plated the sorted YFP-positive SKP cells under conditions that promote differentiation and survival of Schwann cells ([@bib2]). After 1--2 weeks, we observed patches of YFP-positive cells with a bipolar Schwann cell morphology that could be decorated with a NECL1-Fc ([Figure 2](#fig2){ref-type="fig"}L) that binds to NECL4 on live Schwann cells ([@bib20]). We then used cloning cylinders to isolate the putative SKP-derived Schwann cells (SKP-SCs), replated them, and expanded them under Schwann cell culture conditions ([Figure 2](#fig2){ref-type="fig"}M). These cultures were highly enriched for reporter gene-positive, S100β-positive, NECL1-Fc-positive putative Schwann cells ([Figures 2](#fig2){ref-type="fig"}M and 2N).

We performed two assays to ask whether these were functional Schwann cells. First, we cultured dorsal *Dermo1*^*Cre/+*^*;R26TdTomato*^*fl/+*^ SKP-SCs with axons of neonatal sympathetic neurons in compartmented cultures ([@bib22]). Over 8 days, many TdTomato-positive bipolar SKP-SCs associated tightly with axons ([Figure 3](#fig3){ref-type="fig"}A), as is seen with primary Schwann cells. We also observed a second subpopulation of TdTomato-positive cells with a flattened morphology ([Figure 3](#fig3){ref-type="fig"}A) that did not associate with axons and were presumably SKP-derived myofibroblasts or dermal fibroblasts ([@bib4; @bib26]) that were present in the enriched SKP-SC cultures.

Second, we transplanted dorsal *Dermo1*^*Cre/+*^*;R26YFP*^*fl/+*^ SKP-SCs into the distal sciatic nerve of adult nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice immediately following a nerve crush lesion. Thirty days posttransplantation, we immunostained cross sections through the transplanted nerves for YFP to identify the transplanted cells, βIII-tubulin to identify endogenous axons, and myelin-associated glycoprotein (MAG) to identify myelin profiles. This analysis ([Figure 3](#fig3){ref-type="fig"}B) identified YFP-positive, MAG-positive cells wrapping endogenous axons, indicating that mesenchymally derived SKP-SCs were functional and capable of myelinating in vivo.

Transcriptome Analysis Shows that Mesenchymally Derived SKP-SCs Are Highly Similar to Neural Crest-Derived Nerve Schwann Cells {#sec2.3}
------------------------------------------------------------------------------------------------------------------------------

These data argue that dorsal mesenchymally derived SKPs generate functional Schwann cells in culture. To confirm that these were Schwann cells, we performed microarray analysis to compare them to neural crest-derived Schwann cells from the sciatic nerve. To do this, we made dorsal SKP spheres from adult rats, passaged them three times, dissociated the spheres to single cells, and differentiated them under Schwann cell conditions ([@bib3; @bib2; @bib21]). After 2--3 weeks, we identified Schwann cell colonies visually, isolated them with cloning cylinders, and expanded them in culture. Virtually all of these SKP-SCs were immunopositive for GFAP, S100β, P0, p75NTR, and NECL4 ([Figures 3](#fig3){ref-type="fig"}C and 3E). For comparison, we isolated rat sciatic nerve Schwann cells (nerve-SCs) and expanded them as for the SKP-SCs. Immunostaining for the same Schwann cell markers confirmed that these cultures were almost completely pure ([Figures 3](#fig3){ref-type="fig"}D and 3E).

We then used microarrays to compare the mesenchymally derived SKP-SCs to the neural crest-derived nerve-SCs, analyzing three biological replicates each with the Affymetrix GeneChip Rat Gene 1.0 ST Array (Gene Expression Omnibus \[GEO\] accession number [GSE57519](ncbi-geo:GSE57519){#intref0010}). We also compared these data to our previously published ([@bib13]) microarray data from passage 2 adult rat dorsal trunk SKPs. Spearman rank correlation ([Figure 4](#fig4){ref-type="fig"}A) showed that SKP-SCs and nerve-SCs were highly similar to each other and were both distinct from undifferentiated SKPs. Unbiased hierarchical clustering using correlation distance and Ward's clustering method confirmed that the SKP-SC and nerve-SC groups were highly similar but distinct from undifferentiated SKPs ([Figure 4](#fig4){ref-type="fig"}B) with high confidence (approximately unbiased \[AU\] p value and bootstrap probability \[BP\] values between 95 and 100). Nonetheless, the SKP-SC and nerve-SC groups clustered independently, indicating reproducible but minor differences between the two.

To further investigate these similarities and differences, differential expression analysis was performed using the LIMMA bioconductor package ([@bib23; @bib29]). This analysis demonstrated that only 331 genes showed significant differences of 2-fold or greater between the SKP-SCs and nerve-SCs, while 3,511 were different between SKP-SCs and undifferentiated SKPs (p \< 0.05, BH) ([Figure 4](#fig4){ref-type="fig"}C). Moreover, less than 2% of genes were significantly different between the two Schwann cell populations, while 17% were significantly different between SKP-SCs and undifferentiated SKPs ([Figure 4](#fig4){ref-type="fig"}D).

As a further comparison, we analyzed expression of 48 genes that are associated with different stages of Schwann cell differentiation ([Figure 4](#fig4){ref-type="fig"}E) ([@bib12]). A heatmap of the microarray data showed that SKP-SCs and nerve-SCs were very similar with regard to these Schwann cell genes and that both were distinct from SKPs. RT-PCR for a subset of these---*P0*, *Krox20*, *Sox10*, and *Oct6* mRNAs ([Figure 4](#fig4){ref-type="fig"}F)---confirmed that they were approximately similar in the SKP-SC and nerve-SC populations.

We previously showed that mesodermally derived dorsal SKPs and neural crest-derived facial SKPs differentially expressed genes diagnostic of their embryonic origin ([@bib13]). We asked whether dorsal SKP-SCs retained this memory by performing RT-PCR for two of the dorsal SKPs genes: *Hoxa5* and *Hoxc6* ([Figure 4](#fig4){ref-type="fig"}G). While *Hoxa5* mRNA was not detectable in either facial or dorsally derived SKP-SCs, *Hoxc6* mRNA was still expressed in dorsal SKP-SCs ([Figure 4](#fig4){ref-type="fig"}G), indicating that they retain some memory of their mesodermal origin.

Endogenous Dermo1-Positive Mesenchymal Cells Do Not Make Schwann Cells following Injury In Vivo {#sec2.4}
-----------------------------------------------------------------------------------------------

To ask whether mesenchymal SKPs ever made Schwann cells in vivo as they did in culture, we performed injury experiments. First, we performed full-thickness skin punch wounds, which transect skin nerves that regenerate over the ensuing few weeks. We performed these injuries on *D*e*rmo1*^*Cre/+*^*;R26TdTomato*^*fl/+*^ mice that also carried a *Sox2:EGFP* reporter gene, since this labels Schwann cell precursors following skin injury ([@bib14]). Nine days postinjury, when the skin was healed, we immunostained sections for enhanced GFP (EGFP) to detect the *Sox2* reporter and S100β or p75NTR, which label Schwann cells and their precursors within skin ([@bib14]). TdTomato expression was also visualized to detect the *Dermo1Cre* reporter. This analysis ([Figures 5](#fig5){ref-type="fig"}A and 5B) showed that TdTomato-positive cells within regenerated skin were never positive for EGFP, S100β, or p75NTR.

We also performed nerve injury experiments. The sciatic nerve of adult De*rmo1*^*Cre/+*^*;R26TdTomato*^*fl/+*^ mice was crushed and longitudinal nerve sections were immunostained 2 weeks later for TdTomato and S100β or GFAP. As in the uninjured nerve ([Figure 1](#fig1){ref-type="fig"}F), TdTomato-positive cells were not colabeled for S100β or GFAP ([Figures 5](#fig5){ref-type="fig"}C and 5D). Thus, *Dermo1*-tagged mesenchymal cells do not apparently differentiate into Schwann cells in either the skin or the nerve, even following injury.

Human SKPs Can Be Generated from Both Facial and Foreskin Dermis, and Those from the Foreskin Express Genes Characteristic of Mesodermally Derived Rodent SKPs {#sec2.5}
--------------------------------------------------------------------------------------------------------------------------------------------------------------

We next asked whether human SKPs of nonneural crest origin could generate Schwann cells. By analogy to other vertebrates, it is thought that human facial dermis is neural crest derived whereas dermis elsewhere is of mesodermal origin. We therefore compared human SKPs made from human facial versus foreskin dermis to provide support for the idea that, like the dermis itself, they were of two different embryonic origins.

For this analysis, SKPs were isolated from neonatal human foreskin as previously described ([@bib28]). We also used the same technique to isolate SKPs from discarded facial tissue of children younger than 2 years old that were undergoing facial reconstruction surgery. Immunostaining of the facial SKPs after one passage showed that they expressed fibronectin, vimentin, and versican ([Figures 5](#fig5){ref-type="fig"}E--5G), characteristic SKPs markers. Differentiation of facial SKPs under previously defined neural conditions ([@bib28; @bib26]) led to the genesis of βIII-tubulin-expressing cells with the morphology of neurons ([Figure 5](#fig5){ref-type="fig"}H) and SMA-positive myofibroblasts or smooth muscle cells, as demonstrated by immunostaining ([Figure 5](#fig5){ref-type="fig"}I). When facial SKPs were instead plated in Schwann cell conditions, immunostaining identified a small proportion of bipolar cells expressing p75NTR and P0 ([Figure 5](#fig5){ref-type="fig"}J). Finally, when facial SKPs were differentiated under osteogenic conditions ([@bib15]), we observed small alizarin red-positive nodules indicating osteogenic calcium mineralization ([Figure 5](#fig5){ref-type="fig"}K). Thus, human facial SKPs were similar to foreskin SKPs with regard to their differentiation repertoire.

We therefore performed microarrays, comparing four independent samples each of facial and foreskin SKPs on the Affymetrix GeneChip Human Gene 2.0 ST Array (GEO accession number [GSE57519](ncbi-geo:GSE57519){#intref0015}). Spearman rank correlation ([Figure 6](#fig6){ref-type="fig"}A) showed that foreskin and facial SKPs were highly similar to each other, in spite of the genetic variability inherent to human samples. Unbiased hierarchical clustering using correlation distance and Ward's clustering method ([Figure 6](#fig6){ref-type="fig"}B) confirmed this conclusion with high confidence (AU p value and BP values between 88 and 100). Nonetheless, the two groups clustered independently, indicating reproducible differences.

We also performed differential expression analysis using the LIMMA bioconductor package ([@bib23; @bib29]). Only 459 genes, or less than 2%, showed significant differences of 2-fold or greater between foreskin versus facial SKPs (p \< 0.05, BH) ([Figures 6](#fig6){ref-type="fig"}C and 6D). The expression levels of these genes are shown as a heatmap ([Figure 6](#fig6){ref-type="fig"}E). A more limited heatmap showed that ten genes associated with a neural crest-like phenotype were similarly expressed in the two groups ([Figure 6](#fig6){ref-type="fig"}F).

These data indicate that facial and foreskin SKPs were highly similar. Nonetheless, a standard pairwise differential expression comparison using linear models demonstrated that a subset of genes were significantly differentially expressed ([Figure 6](#fig6){ref-type="fig"}G; [Table S1](#mmc2){ref-type="supplementary-material"} available online). We therefore asked whether these two populations differentially expressed genes diagnostic of their different embryonic origins. A heatmap comparison ([Figure 6](#fig6){ref-type="fig"}H) of genes previously shown to distinguish facial versus trunk-derived rodent SKPs ([@bib13]) showed that *MSX1*, *MAB21L2*, and *PAX3*, genes diagnostic of rodent neural crest-derived facial SKPs, were also expressed more highly in human facial SKPs. Conversely, *HOXC9*, *HOXC4*, *HOXC8*, and *ZIC1*, genes diagnostic of rodent mesodermally derived dorsal SKPs, were expressed more highly in human foreskin SKPs ([Figure 6](#fig6){ref-type="fig"}H). These data are therefore consistent with the conclusion that human facial versus foreskin SKPs derive from neural crest versus mesodermal origins, as do their rodent counterparts.

Human Foreskin-Derived SKPs Also Generate Functional Schwann Cells {#sec2.6}
------------------------------------------------------------------

We next asked whether human foreskin SKPs could give rise to functional Schwann cells. When expanded and passaged foreskin SKPs were differentiated under Schwann cell conditions they generated an adherent bed of cells underneath many bipolar, phase-bright cells ([Figure 7](#fig7){ref-type="fig"}A). These bipolar cells were immunopositive for p75NTR and S100β and bound the NECL1-Fc ([Figures 7](#fig7){ref-type="fig"}A and 7B).

We asked whether these putative human SKP-SCs could myelinate by coculturing them with embryonic rat dorsal root ganglion (DRG) neurons treated with cytosine arabinoside to eliminate endogenous rat Schwann cells. These cocultures were treated with fetal bovine serum and ascorbic acid to induce myelination and immunostained 12 days later for myelin basic protein (MBP) to visualize myelin segments and for the paranodal junction-specific protein CASPR. There was no myelination in cultures containing only DRG neurons (data not shown). In contrast, segments of myelin with paranodal junctions were evident in cultures where human SKP-SCs had been added ([Figure 7](#fig7){ref-type="fig"}C). We also immunostained these cocultures with antibodies recognizing just rodent or both rodent and human gliomedin, a node of Ranvier protein ([@bib8]). As predicted, nodes were positively stained with the antibody that recognized human gliomedin, but not with the rat-specific antibody ([Figure 7](#fig7){ref-type="fig"}E). In contrast, in cultures of rat DRG neurons containing endogenous rat Schwann cells that were induced to myelinate, both gliomedin antibodies recognized the nodes ([Figure 7](#fig7){ref-type="fig"}D).

Since foreskin SKP-SCs could myelinate in culture, we asked whether they could also do so in vivo. SKP-SCs were isolated from differentiated SKP cultures by magnetic bead sorting after decorating them with the NECL1-Fc ([Figure 7](#fig7){ref-type="fig"}F), as previously reported for rodent Schwann cells ([@bib24]). We injected these purified SKP-SCs into the sciatic nerves of NOD/SCID mice previously treated with lysolecithin to induce local demyelination ([@bib10]). Transplanted nerves were then immunostained with a human mitochondria-specific antibody. At 4 days posttransplant, many human cells were present in the transplant region and some were aligned along βIII-tubulin-positive axons ([Figure 7](#fig7){ref-type="fig"}G). At 30 days posttransplant, some human mitochondrial antigen-positive cells expressed S100β, a marker for the nonmyelinating Schwann cell phenotype ([Figure 7](#fig7){ref-type="fig"}H). Moreover, cell bodies positive for human mitochondrial antigen were aligned along MBP-positive myelin sheaths that were associated with the paranodal protein CASPR ([Figure 7](#fig7){ref-type="fig"}I), consistent with a myelinating Schwann cell phenotype. Thus, human foreskin-derived SKPs can generate bona fide Schwann cells that myelinate axons both in culture and in vivo.

Discussion {#sec3}
==========

Data presented here provide strong support for the conclusion that rodent and human mesenchymal precursors of nonneural crest origin can, without genetic manipulation, generate a peripheral neural cell type thought only to derive from the neural crest. A key question then is why a dermal mesenchymal precursor would have this potential. During embryogenesis, neural crest precursors give rise to both mesenchymal and peripheral neural cell types ([@bib16]). Some of these neural crest precursors persist in the adult and maintain their dual potential. For example, the precursors that generate facial dermis are neural crest derived, persist in the adult, and, when cultured as SKPs, maintain their neural crest potential ([@bib9; @bib13]). However, while facial dermis is neural crest derived, the rest of the vertebrate dermis is of mesodermal origin ([@bib6; @bib19]), providing a classic example of developmental convergence. Nonetheless, in spite of these different developmental origins, we previously showed that SKPs generated from facial and trunk dermis are highly similar ([@bib13]), and here we show that even mesodermally derived dorsal SKPs can generate bona fide myelinating Schwann cells. We propose that, while surprising, the peripheral neural differentiation potential of dermal mesenchymal precursors is another example of the developmental convergence of neural crest and mesodermal lineages.

A second key question arising from these findings is whether adult mesenchymal precursors ever generate peripheral neural cells in vivo. Data presented here argue that this is unlikely. In particular, the *Dermo1Cre* mesenchymal reporter gene was not expressed by Schwann cells in normal skin or following injury to the skin or sciatic nerve, consistent with our recent work showing that Schwann cells in regenerating skin were all of neural crest origin ([@bib14]). Thus, the in vivo environment restricts these dermal mesenchymal precursors so that they do not cross lineage boundaries, much as previously described for the neural crest developmentally ([@bib16]).

A third question involves directed reprogramming of mouse embryonic fibroblasts or dermal fibroblasts to neural cell types ([@bib1]). These findings are interpreted as reflecting genetically driven reprogramming/transdifferentiation, but our data suggest that these manipulations might be unmasking an intrinsic peripheral neural potential in endogenous dermal mesenchymal precursors rather than transdifferentiating cells incapable of making neural cell types.

A fourth question is whether mesenchymal precursors in other tissues can cross the mesodermal/neural crest lineage boundary. In this regard, mesenchymal tissues such as bone and adipose tissue are also developmentally generated by both the neural crest and mesoderm, and bone marrow and adipose-derived mesenchymal precursors have been reported to generate cells with neural properties (for example, see [@bib5]). However, since neural crest precursors exist in the nerves that innervate virtually all tissues, and since these precursors were not definitively removed from the mesenchymal precursor preparations in most studies, then this remains an open question.

Our findings demonstrate that nonneural crest-derived mesenchymal precursors can differentiate into bona fide peripheral glia in the absence of genetic manipulation. Our study adds to a body of work showing that somatic tissue precursors display greater potential when cultured than they do in vivo. These findings therefore set the stage for asking about the intrinsic nature and flexibility of lineage bias and for defining the cues that restrict precursor cells to ensure that they only generate appropriate progeny in vivo.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

This study was approved by the animal care committee of the Hospital for Sick Children, in accordance with Canadian Council on Animal Care guidelines. *Dermo1*^*Cre/+*^ ([@bib31]), *R26TdTomato*^*fl/+*^ ([@bib18]), *R26YFP*^*fl/+*^ ([@bib25]), and *Sox2*^+/EGFP^ ([@bib7]) mice were as described ([@bib14]). Sprague-Dawley rats, either wild-type (Charles River) or GFP expressing (SLC, Japan), were purchased and maintained as described ([@bib4]). NOD/SCID mice were obtained from Jackson Laboratory. Animal care after surgery was as described in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Primary Cultures and Differentiation {#sec4.2}
------------------------------------

Rodent SKPs were cultured and passaged as previously described ([@bib27; @bib4; @bib9]) and detailed in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}. For human SKPs ([@bib28]), anonymized foreskin tissue from voluntary circumcisions or facial tissue from facial reconstruction surgeries of young children were obtained with approval of the research ethics board of the Hospital for Sick Children.

Differentiation of rodent and human Schwann cells was performed as described ([@bib2; @bib21]) ([Supplemental Experimental Procedures](#app3){ref-type="sec"}). Differentiation of human SKPs was performed as described ([@bib15; @bib28]) ([Supplemental Experimental Procedures](#app3){ref-type="sec"}). Schwann cells were isolated from the sciatic nerves of 1.5- to 2-month-old Sprague-Dawley rats as detailed in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}. Compartmented cultures of neonatal rat sympathetic neurons were prepared as previously described ([@bib22]). Seven days after cultures were established, SKP-SCs were plated in side compartments as detailed in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}. For myelination assays, dissociated embryonic day 15 DRG neurons were prepared as described ([@bib8]), and human SKPs differentiated under Schwann cell conditions were added for 4 days and switched to myelination conditions for an additional 12 days ([Supplemental Experimental Procedures](#app3){ref-type="sec"}).

Cell Sorting {#sec4.3}
------------

Dorsal skin from *Dermo1*^*Cre/+*^*;R26YFP*^*fl/+*^ mice was dissociated to single cells and sorted for YFP on a MoFlo (Dako) with viable cells identified by propidium iodide exclusion. YFP-positive and negative fractions were collected and resuspended in SKPs growth media for 10 days to quantify sphere growth. Alternatively, primary-passage SKP spheres from *Dermo1*^*Cre/+*^*;R26YFP*^*fl/+*^ or *Dermo1*^*Cre/+*^*;R26TdTomato*^*fl/+*^ mice were dissociated to single cells and sorted for YFP or TdTomato. In all flow cytometry experiments, wild-type littermates were used to determine negative levels for setting gates. Magnetic sorting of human SKP-SCs was based on [@bib24], where NECL4 was bound by soluble recombinant, fluorescently prelabeled Necl1-human Fc (Necl1-Fc), as modified for magnetic bead sorting (described in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}).

In Vivo Injury and Transplantation Experiments {#sec4.4}
----------------------------------------------

Young-adult NOD/SCID mice were used for transplant experiments. For mouse cell experiments, the sciatic nerve was crushed and 2 × 10^5^ cells were injected distal to the crush site. For human cell experiments, myelin was locally ablated in the sciatic nerve by injection of 1% lysolecithin (Avanti Polar Lipids) in Locks solution ([@bib10]) and 2 × 10^5^ cells were injected 6 days later as described ([@bib21]). Additional details are in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}. For adult skin experiments, 6 mm full-thickness punch wounds were administered to the dorsal trunk as described ([@bib14]).

Immunostaining and Microscopy {#sec4.5}
-----------------------------

Immunostaining of cells and tissue sections was performed as previously described ([@bib4; @bib14]). Antibodies and details of microscopy are in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Microarrays and Statistical Analyses {#sec4.6}
------------------------------------

RNA was isolated from three biological replicates of passage 2 adult rat nerve-derived and SKP-derived Schwann cells and from four different replicates each for human facial versus foreskin SKPs using TRIzol reagent (Invitrogen) and purified with the RNeasy Mini Kit (QIAGEN). RNA was converted into cDNA by reverse transcription with the Ambion Whole Transcript (WT) Expression Kit (Applied Biosystems). cDNA was hybridized to the GeneChip Rat Gene 1.0 Sense Target ST Array or the GeneChip Human Gene 2.0 Sense Target ST Array (Affymetrix) using the GeneChip Fluidics Station 450 (Affymetrix). The hybridized microarray image was scanned with the GeneChip Scanner 3000 7G (Affymetrix). Raw probe intensity values were background corrected, normalized with quantile normalization, transformed into the log~2~ scale, and summarized into probesets using the Robust Multichip Analysis (RMA) algorithm at the gene level in the Affymetrix Expression Console program. To reduce the false-discovery rate, only probesets for annotated genes were used for the LIMMA bioconductor package in R. Bayesian statistics were calculated using the eBayes function and the Benjamini-Hochberg (BH) procedure was used to correct for multiple testing errors. Those genes with BH-corrected p value \< 0.05 were considered statistically significant. Spearman rank correlation was generated in Affymetrix Expression Console. Unbiased hierarchical clustering was performed in R with the pvclust package using correlation distance and Ward's clustering method. Heatmaps were generated using the gplots package in R.

RT-PCR for Selected Genes {#sec4.7}
-------------------------

RNA was isolated from rat nerve SCs, dorsal SKP-SCs, facial SKP-SCs, dorsal SKPs, and facial SKPs using TRIzol reagent and purified with the Ambion RiboPure kit (Invitrogen). Reverse transcription was performed using the RevertAid H Minus First Strand cDNA Synthesis kit (K1632, Thermo Scientific). Primers are listed in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Accession Numbers {#app1}
=================

The GEO accession number for the rat and human microarray data reported in this paper is [GSE57519](ncbi-geo:GSE57519){#intref0020}.

Supplemental Information {#app3}
========================

Document S1. Supplemental Experimental ProceduresTable S1. List of Genes from Analysis of Human SKPs Microarray as Shown in Figure 6EGenes determined to be greater than 2-fold different between human facial foreskin SKPs (i.e., greater than 1 on the log~2~ scale) with an adjusted p value less than 0.05 are listed.Document S2. Article plus Supplemental Information
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![*Dermo1*^*Cre/+*^-Based Lineage Tracing Shows that Dorsal SKPs Are of Mesenchymal Origin\
(A--E) Dorsal backskin sections from adult *Dermo1*^*Cre/+*^*; R26YFP*^*fl/+*^ mice were immunostained for YFP (*Dermo1Cre*) and cell-type-specific markers.\
(A) Low-magnification micrograph of hair follicles (arrows).\
(B and C) Anagen hair follicles immunostained for YFP (green) and NCAM (B) or SMA (C; red in both). Arrow in (B) denotes double-positive cells in the follicle dermal papilla and arrowheads YFP-positive cells in interfollicular dermis. Arrows in (C) denote double-positive follicle dermal sheath cells.\
(D) Anagen hair follicle immunostained for YFP (green) and the melanocyte marker tyrosinase (red; right panel shows the merge). Arrows denote tyrosinase-positive melanocytes that are negative for YFP.\
(E) Interfollicular dermis immunostained for YFP (green) and the Schwann cell marker S100β (red; the right panel shows the merge). Arrows indicate an S100β-positive, YFP-negative skin nerve.\
(F--I) Longitudinal sections of the adult *Dermo1*^*Cre/+*^*; R26TdTomato*^*fl/+*^ sciatic nerve immunostained for TdTomato (*Dermo1Cre*; red) and S100β (F and G), fibronectin (H), or CD34 (I; green in all cases). The image in (F) is at low magnification, while (G)--(I) are at high magnification. Arrow in (G) denotes a TdTomato-positive cell that is negative for S100β, while arrows in (H) and (I) show double-positive cells.\
In (A)--(I), sections were counterstained with Hoechst 33258 (blue) to highlight nuclei. Scale bars represent 100 μm (A), 25 μm (B, D, and G), 50 μm (C and F), and 15 μm (E, H, and I).](gr1){#fig1}

![SKPs Generate Schwann Cells that Can Be Traced to the Dermal Mesenchymal Lineage\
(A--C) Primary-passage SKPs generated from the dorsal skin of postnatal day 2 *Dermo1*^*Cre/+*^*; R26YFP*^*fl/+*^ mice, immunostained for YFP (A and B, green) and Sox2 (B, red) or fibronectin (C, white) and nestin (C, red).\
(D) Confocal micrograph of a section through a secondary-passage SKP sphere generated from an adult *Dermo1*^*Cre/+*^*; R26TdTomato*^*fl/+*^ mouse.\
(E--H) Secondary-passage SKP spheres generated from *Dermo1*^*Cre/+*^*; R26YFP*^*fl/+*^ mice immunostained for YFP (E and F, green) and nestin (F, red), fibronectin (G, white), or SOX2 (H, red).\
(I and J) Dorsal skin cells from P2 *Dermo1*^*Cre/+*^*; R26YFP*^*fl/+*^ mice were sorted for YFP expression, as shown in the flow cytometry plot in (I), and the YFP-positive (*Dermo1Cre*^*+*^) versus YFP-negative (*Dermo1Cre*^*−*^) cells were cultured as SKPs for 10 days. Bright-field and fluorescence micrographs (J) show that the YFP-positive cells (green) make SKP spheres (arrows in the top two panels in J), while the YFP-negative cells do not (bottom two panels in J).\
(K) Flow cytometry plot of dorsal SKPs generated from P2 *Dermo1*^*Cre/+*^*; R26YFP*^*fl/+*^ mice, dissociated and sorted for YFP expression.\
(L) YFP-positive SKP cells (green) were sorted as in (K), differentiated under Schwann cell conditions for 14 days, and decorated with NECL1-Fc (red). Arrows denote double-positive cells.\
(M and N) SKP-SCs generated as in (K) and (L), isolated, expanded, and immunostained for YFP (M and N, green) and S100β (N, white) and decorated with the NECL1-Fc (M and N, red).\
Scale bars represent 200 μm (A, E, and L), 50 μm (B, C, F--H, and N), 25 μm (D), and 100 μm (J and M).](gr2){#fig2}

![SKP-SCs Exhibit Functional and Phenotypic Similarities to Nerve-SCs\
(A and B) Dorsal SKPs from P2 *Dermo1*^*Cre/+*^*; R26TdTomato*^*fl/+*^ or *Dermo1*^*Cre/+*^*; R26YFP*^*fl/+*^ mice were sorted for reporter gene expression, plated in Schwann cell conditions, and the putative SKP-SCs were enriched using cloning cylinders and expanded. (A) *Dermo1*^*Cre/+*^*; R26TdTomato*^*fl/+*^ SKP-SCs cocultured in compartments with sympathetic axons and immunostained 8 days later for TdTomato (red) and the axonal marker βIII-tubulin (green; right panel shows the merge). Arrows and arrowheads denote TdTomato-positive cells that are or are not associated with axons, respectively. (B) Confocal micrographs of a sciatic nerve crushed and transplanted 30 days previously with *Dermo1*^*Cre/+*^*; R26YFP*^*fl/+*^ SKP-SCs and immunostained for YFP (green) to detect mesenchymally derived SKP-SCs, βIII-tubulin to show axons (white), and myelin-associated glycoprotein (MAG) (red; the right panel shows the merge) to detect myelin profiles. Section was counterstained with Hoechst (blue). Arrow denotes a YFP-positive cell that has generated a MAG-positive myelin sheath around an axon.\
(C and D) Micrographs of purified, expanded Schwann cells made from tertiary-passage dorsal SKPs (C) or from adult sciatic nerve (D) that were used for the microarray analysis. Cells were immunostained for various combinations of the Schwann cell markers P0, p75NTR, GFAP, and S100β or were decorated with NECL1-Fc and immunostained for NECL4.\
(E) The proportion of S100β-positive cells was determined in immunostained Schwann cell cultures as shown in (C) and (D). n = 3 different preparations each.\
Error bars denote the SEM. Scale bars represent 50 μm (A) and 25 μm (B--D).](gr3){#fig3}

![Dorsal SKP-SCs Are Highly Similar to Nerve-SCs but Are Distinct from Dorsal SKPs\
Microarray analysis (GEO accession number [GSE57519](ncbi-geo:GSE57519){#intref0030}) of three independent isolates each of dorsal adult rat SKP-SCs (SKP-SC 1-3 or S1-3) or adult rat sciatic nerve-SCs (Nerve-SC 1-3 or N1-3), both passaged twice as Schwann cells, and adult rat dorsal trunk SKPs (Trunk SKPs 1-3 or TS1-3).\
(A) Spearman rank correlation matrix computed for the microarray experiments based upon all of the 20,412 probesets, as visualized by color-coding, with red and blue representing the most highly and the least correlated samples, respectively.\
(B) Microarray data sets were clustered using unbiased hierarchical clustering with correlation distance and Ward's clustering method. AU and BP values were all between 95 and 100, indicating high confidence.\
(C and D) Venn diagrams (C) or bar graphs (D) of pair-wise comparisons between dorsal SKP-SCs versus nerve-SCs and dorsal SKP-SCs versus dorsal SKPs using an analysis similar to one-way ANOVA implemented in the LIMMA bioconductor package for genes that are 2-fold significantly different (p \< 0.05, BH).\
(E) A heatmap of the microarray data for 48 genes expressed in Schwann cells during their differentiation from neural crest precursors to myelinating Schwann cells. Red and green indicate the highest and lowest relative levels of expression, as defined by the color key.\
(F) RT-PCR analysis of the Schwann cell mRNAs *Krox20*, *Sox10*, *P0*, and *Oct6* mRNAs in equal amounts of total RNA from rat dorsal SKP-SCs and rat nerve-SCs. Each lane represents an independent isolation. *Gapdh* mRNA was used as a control. −RT refers to the nerve-SC samples analyzed without addition of reverse transcriptase.\
(G) RT-PCR analysis of *Hoxa5* and *Hoxc6* mRNAs in equal amounts of total RNA from two to three independent isolates of dorsal versus facial SKPs and dorsal SKP-SCs versus facial SKP-SCs. *Gapdh* mRNA was used as a positive control, and −RT refers to the dorsal trunk SKP samples without reverse transcriptase.](gr4){#fig4}

![Mesenchymally Derived *Dermo1*-Positive Cells Do Not Generate Schwann Cells following Injury, and Characterization of SKPs Generated from Human Facial Skin\
(A and B) Confocal micrographs of sections through the regenerated dorsal dermis of adult *Dermo1^Cre/+^;R26TdTomato^fl/+^*; Sox2:EGFP mice 9 days following a punch wound, immunostained for EGFP (A and B, green) to detect the Sox2 reporter and for S100β (A, blue) or p75NTR (B, blue). TdTomato (A and B, red) was visualized without immunostaining. The right panels show the merges. Arrows indicate cells that coexpress Sox2:EGFP and S100β (A) or p75NTR (B), but not the Dermo1Cre reporter. Arrowheads identify cells that are only positive for TdTomato.\
(C and D) Confocal micrographs of longitudinal sections through the regenerated sciatic nerve of an adult *Dermo1^Cre/+^;R26TdTomato^fl/+^* mouse 14 days following nerve crush, immunostained for TdTomato (red) and either S100β (C, green) or GFAP (D, green). Arrows indicate cells positive only for the Dermo1Cre reporter, and arrowheads in (C) denote cells positive only for S100β.\
(E--G) Secondary-passage human facial SKP spheres immunostained for fibronectin (E, green), vimentin (F, red), or versican (G, red) and the proliferation marker Ki67 (G, green).\
(H and I) Human facial SKPs differentiated under neurogenic conditions, immunostained for βIII-tubulin to identify putative neurons (H, green, arrows) or smooth muscle actin (SMA) to detect smooth muscle cells/myofibroblasts (I, red, arrows).\
(J) Human facial SKPs differentiated under Schwann cell conditions and immunostained for p75NTR (green) and P0 (red). Arrows denote a double-positive cell with the morphological characteristics of a Schwann cell.\
(K) Human facial SKPs differentiated under osteogenic conditions and stained with alizarin red to detect bone mineralization. Arrows denote positive nodules.\
SKPs in (E)--(J) were counterstained with Hoechst 33258 (blue). Scale bars represent 25 μm (A--D) and 50 μm (E--K).](gr5){#fig5}

![Human Facial versus Foreskin-Derived SKPs Are Highly Similar at the Transcriptome Level but Differentially Express Genes Indicative of Distinct Origins\
Microarray analysis (GEO accession number [GSE57519](ncbi-geo:GSE57519){#intref0035}) of four samples each of neonatal human facial SKPs (facial SKPs 1 to 4) and foreskin SKPs (FS or foreskin SKPs 1 to 4).\
(A) Spearman rank correlation matrix computed for the microarray experiments based upon all of the 26,689 probesets, as visualized by color-coding, with red and blue representing the most and least highly correlated samples, respectively.\
(B) Microarray data sets were clustered using unbiased hierarchical clustering with correlation distance and Ward's clustering method. AU and BP values between 88 and 100 indicate high confidence.\
(C and D) Venn diagram (C) or bar graph (D) depicting numbers of genes identified as 2-fold significantly different (p \< 0.05, BH) using an analysis similar to one-way ANOVA implemented in the LIMMA bioconductor package.\
(E) Heatmap of the microarray data for 459 genes that were 2-fold significantly different (p \< 0.05, BH).\
(F) Heatmap of the microarray data for genes associated with a neural crest phenotype.\
(G) Volcano plot of a standard pairwise differential expression comparison of facial versus foreskin SKPs. A positive log fold change indicates greater expression in facial SKPs relative to foreskin SKPs.\
(H) Heatmap of the microarray data for genes previously shown to differ between rodent neural crest-derived facial SKPs and mesodermally derived dorsal trunk SKPs ([@bib13]).\
See also [Table S1](#mmc2){ref-type="supplementary-material"}.](gr6){#fig6}

![Human Foreskin-Derived SKPs Can Differentiate into Functional, Myelinating Schwann Cells\
(A) Bright-field (left) and fluorescence (right) micrographs of living human SKPs differentiated in Schwann cell conditions and decorated with the NECL1-Fc (red).\
(B) Micrographs of cultures as in (A) that were decorated with NECL1-Fc (red), fixed and immunostained for S100β (blue) and p75NTR (green).\
(C) Human SKP-derived Schwann cells were cocultured with embryonic rat sensory neurons, and myelination was induced for 12 days. Cocultures were immunostained for MBP (green) and the paranodal junction-specific protein CASPR (red, arrows) to visualize myelin segments. The boxed areas show the indicated regions at higher magnification, with the MBP and CASPR signals shown separately. Arrows denote paranodal junctions.\
(D and E) Cultures similar to those in (C), where DRG neurons were cocultured with endogenous rat Schwann cells (D) or with human SKP-SCs (E). Cocultures were immunostained for MBP (blue) and with antibodies that recognize either rat gliomedin alone (green; rGldn) or both human and rat gliomedin (red; panGldn). Arrows in (D) denote puncta that are positive with both gliomedin antibodies, while the arrow in (E) denotes a human node that is recognized by the pan-gliomedin, but not by the rat-specific gliomedin, antibody.\
(F) Bright-field (left) and fluorescence (right) micrographs of living human SKP-SCs that were decorated with the NECL1-Fc (red) and then sorted using magnetic beads (dark precipitates, left).\
(G--I) Micrographs of longitudinal sections through the sciatic nerves of NOD/SCID mice that were demyelinated using lysolethicin and were then transplanted with a sorted, enriched population of human SKP-SCs (as seen in F). Sections were immunostained either 4 days (G) or 1 month (H and I) after transplantation. In (G), sections were immunostained for human mitochondrial antigen to visualize transplanted cells (red) and βIII-tubulin (green) to visualize axons. The right panel shows the merge, and the dashed line demarcates the regions that did and did not receive transplanted cells. Arrows denote human SKP-SCs closely associated with endogenous axons (green, arrowhead). In (H), 1 month following transplantation with human SKP-SCs, longitudinal sections of the transplanted nerve were immunostained for human mitochondrial antigen (green) and the Schwann cell protein S100β (red). Arrows denote a double-positive cell with the morphology of a nonmyelinating Schwann cell. DAPI (blue) was used as nuclear counterstain in (G and H). In (I), sections were immunostained for human mitochondrial antigen (red, arrows), MBP to show myelin segments (white), and CASPR to show nodes of Ranvier (green, arrowhead). The top two panels show the merge of signals for human mitochondrial antigen and CASPR and the bottom panel the merge of all three signals. The boxed area in the top panel is shown at higher magnification in the bottom two panels.\
Scale bars represent 100 μm (A and F), 30 μm (B), 10 μm (C--E), 50 μm (G), and 20 μm (H and I).](gr7){#fig7}
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